Who owns Alentis Therapeutics?

Alentis Therapeutics is currently owned by Jeito Capital, through Jeito I, since 2021.

When did Jeito Capital acquire Alentis Therapeutics?

Jeito Capital acquired Alentis Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Alentis Therapeutics

Alentis Therapeutics

Biotech·

Switzerland·Active·5yr hold

Alentis Therapeutics is a healthcare company, headquartered in France.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Jeito Capital

Key facts

HQFrance

SectorHealthcare

Basel-based clinical-stage biotech developing anti-Claudin-1 antibodies for solid tumors and organ fibrosis; Jeito Capital co-invested in…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Jeito I

6 comparable biotech deals from other GPs

Start free

Already a member? Sign in

Data refreshed weekly · Sourced from public filings